Bangladeš - angleščina - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd. - clonazepam - tablet - .5 mg

Bangladeš - angleščina - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd. - clonazepam - tablet - 2 mg

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ipsen consumer healthcare - magnesium sulfate heptahydrate 3,276 g; sodium sulfate anhydrous 17,51 g; potassium sulfate 3,13 g - concentrate for oral solution - magnesium sulfate heptahydrate 18.61 mg/ml; potassium sulfate 17.78 mg/ml; sodium sulfate 99.49 mg/ml - mineral salts in combination

Bangladeš - angleščina - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd. - clonazepam - tablet - 1 mg

Bangladeš - angleščina - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd, unit-2 - clonazepam - tablet - .5 mg

Bangladeš - angleščina - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd, unit-2 - clonazepam - tablet - 1 mg

Bangladeš - angleščina - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd, unit-2 - clonazepam - tablet - 2 mg

Singapur - angleščina - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - cardiovascular - intended for repair of pericardial structures and for use as a prosthesis for the surgical repair of soft tissue deficiencies, which include: defects of the abdominal and thoracis wall, hernias (including diaphragmatic, femoral, incisional, inguinal, lumbar, paracolostomy, scrotal, and umbilical) and intracardiac and great vessel repair.